/
We have developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Our current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.
The business is unprofitable at the operating level (-292.89% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 19.6% YoY with margins expanding 43.6pp.
Negative free cash flow of -$6M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$2M
▲ +19.6% YoY
Net Income (TTM)
-$7M
▼ -3.2% YoY
Op. Margin
-312.29%
▲ +43.6pp YoY
ROIC
-48.17%
▲ +37.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$6M
▲ +3.7% YoY
Op. Cash Flow (TTM)
-$6M
▲ +4.7% YoY
Net Debt
-$4M
Net Cash Position
Cash & Equiv.
$7M
5Y CAGR: +51.1%
Continue Research